Reappointment of Dr. Prerna Goradia as an Independent Director of the Company
GRAUWEIL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Grauer & Weil (India) Limited announced the outcome of its board meeting held on May 26, 2025. The board approved the standalone and consolidated audited financial results for Q4 and FY ended March 31, 2025, with an unmodified (clean) opinion from statutory auditors M/s M M Nissim & Co. LLP. The board recommended a 50% dividend, i.e. Re. 0.50 per equity share of Re. 1 face value, for FY 2024-25, subject to shareholder approval. The 67th Annual General Meeting is scheduled for August 11, 2025. Dr. Prerna Goradia was reappointed as an Independent Non-Executive Director for another 5-year term (July 29, 2025 to July 28, 2030), subject to shareholder approval. The board also appointed GMJ & Associates as Secretarial Auditors for 5 years (FY26–FY30), V.J. Talati & Co. as Cost Auditors for FY26, and SCA & Associates as Internal Auditors for FY26, all subject to shareholder approval.
A clean audit opinion and a 50% dividend signal steady, profitable operations and shareholder reward, though the dividend payout is modest given the Re. 1 face value. Director and auditor appointments are routine renewals, suggesting governance continuity with no red flags.